These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2336712)

  • 21. Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts.
    Hultman CS; Cairns BA; deSerres S; Frelinger JA; Meyer AA
    Transplantation; 1995 Sep; 60(6):584-9. PubMed ID: 7570955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary observation of prolonged survival of cultured epidermal allografts].
    Zhao YB
    Zhonghua Wai Ke Za Zhi; 1992 Feb; 30(2):104-6, 125-6. PubMed ID: 1395963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin.
    Jamshidi F; De Fazio SR; Gozzo JJ
    Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney.
    Ng TF; Osawa H; Hori J; Young MJ; Streilein JW
    J Immunol; 2002 Nov; 169(10):5601-6. PubMed ID: 12421938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.
    Yamada J; Dana MR; Zhu SN; Alard P; Streilein JW
    Arch Ophthalmol; 1998 Oct; 116(10):1351-7. PubMed ID: 9790635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
    Erdag G; Morgan JR
    Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of thyroid allograft survival following organ culture. Alteration of tissue immunogenicity.
    Hullett DA; Landry AS; Leonard DK; Sollinger HW
    Transplantation; 1989 Jan; 47(1):24-7. PubMed ID: 2911873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light microscopic and immunohistochemical features in serial biopsies of epidermal versus dermal allografts.
    Hoffman DK; Sibley RK; Korman JM; Press BH
    Ann Plast Surg; 1994 Sep; 33(3):295-9. PubMed ID: 7985966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of allograft tolerance with neonatal skin.
    Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
    Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes.
    Hunt JP; Hunter CT; Brownstein M; Hultman CS; deSerres S; Bracey L; Frelinger J; Meyer AA
    J Surg Res; 1998 Apr; 76(1):32-6. PubMed ID: 9695735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated rejection of H-2-incompatible skin allografts in the absence of specific cytotoxic antibodies.
    Aitouche A; Touraine JL
    Transplantation; 1993 Sep; 56(3):503-8. PubMed ID: 8212140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerogenic behavior of skin allografts from neonatal mice.
    Markees TG; De Fazio SR; Gozzo JJ
    Transplantation; 1994 Nov; 58(9):1008-14. PubMed ID: 7974727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are histocompatibility antigens in neonatal skin grafts truly tolerogenic?
    Polácková M; Svec M; Viklický V
    Folia Biol (Praha); 1979; 25(2):95-100. PubMed ID: 378720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.